Covered recipient · General Payments record
MIGUEL ALEMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$1,014.89
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.96 | 18 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $166.18 | 10 |
| Lilly USA, LLC | $28.81 | 2 |
| Abbott Laboratories | $20.20 | 1 |
| Novo Nordisk AS | $19.26 | 1 |
| Amgen Inc. | $18.18 | 1 |
| DEXCOM, INC. | $17.06 | 1 |
| Astellas Pharma US Inc | $16.53 | 1 |
| IBSA Pharma Inc. | $15.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.20 | 02/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818420881 | CMS |
| AbbVie Inc. | $20.14 | 01/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793843983 | CMS |
| AbbVie Inc. | $21.75 | 02/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793843987 | CMS |
| AbbVie Inc. | $14.34 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793843991 | CMS |
| AbbVie Inc. | $15.86 | 04/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793843995 | CMS |
| AbbVie Inc. | $22.55 | 06/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793843999 | CMS |
| AbbVie Inc. | $21.63 | 06/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793844003 | CMS |
| AbbVie Inc. | $0.69 | 06/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793844007 | CMS |
| AbbVie Inc. | $14.27 | 07/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793844011 | CMS |
| AbbVie Inc. | $16.10 | 07/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793844015 | CMS |
| AbbVie Inc. | $18.85 | 08/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793844019 | CMS |
| Amgen Inc. | $18.18 | 06/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825630159 | CMS |
| Astellas Pharma US Inc | $16.53 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821244181 | CMS |
| DEXCOM, INC. | $17.06 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845267271 | CMS |
| IBSA Pharma Inc. | $15.74 | 06/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 792499697 | CMS |
| Lilly USA, LLC | $12.98 | 02/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818606261 | CMS |
| Lilly USA, LLC | $15.83 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818591027 | CMS |
| Novo Nordisk Inc | $19.26 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836092041 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.